COMMUNIQUÉS West-GlobeNewswire

Align Technology and DentalXP Launch Global Orthodontic Aligner Fellowship Program to Help Integrate Invisalign Treatment Into Practices
07/08/2018
Online Certification Program Endorsed by New York University (NYU) College of Dentistry, Provides Modular Training for Align’s End-to-End Digital Workflow Including iTero Scanning Technology SAN JOSE, Calif., Aug. 07, [...]
REVA Medical Reports Second Quarter 2018 Financial Results
07/08/2018
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today provided a business update [...]
Emerald Health Expands into Analytical Testing and Import/Export -- CFN Media
07/08/2018
SEATTLE, WA, Aug. 07, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article [...]
Axim® Biotechnologies Announces Positive Results From Stability And Dissolution Tests On Medchew Rx Showing Greater Than 90% Availability
07/08/2018
Results From Stability and Dissolution Testing on MedChew Rx® Controlled-Release Chewing Gum Show Over 90% Availability of Cannabinoid Molecules NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. ( [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
07/08/2018
FIT Biotech Oy Company release August 7, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
International Endeavors Corp. (IDVV) Subsidiary Applies for Funding under the Canadian CA$3 Billion Agricultural Program
07/08/2018
LAS VEGAS, Aug. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC: IDVV) announces, as according to Forbes , that during July 2018, for the first time, the Canadian government made [...]
Novelion Therapeutics Reports Second Quarter 2018 Financial Results
07/08/2018
Following recent marketing approval in both generalized and partial lipodystrophy indications, European launch of MYALEPTA® has commenced VANCOUVER, British Columbia, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Novelion [...]
Bellerophon Announces Results of Interim Analysis of Phase 3 INOvation-1 Study Evaluating INOpulse® for Treatment of Pulmonary Arterial Hypertension
07/08/2018
WARREN, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that the Data Monitoring Committee [...]
Viveve Announces FDA Approval to Continue VIVEVE II Clinical Study
07/08/2018
Agency determines one-month safety data sufficient in first-stage and grants continued enrollment of up to 100 subjects in second stage of sexual function trial ENGLEWOOD, Colo., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Viveve [...]
Achroma Corp. Announces Global Survey Results of 226 People with Achromatopsia
07/08/2018
More than One-Third of People with Achromatopsia Were Misdiagnosed with Retinal or Cone Dystrophy Only 58% of Adults and 65% of Children with Achromatopsia Have Received Genetic Testing BUTLER, Pa., Aug. 07, 2018 (GLOBE [...]
Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2018 Financial Results
07/08/2018
Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday August 14, 2018 NEWTOWN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage [...]
Proteon Therapeutics Announces Second Quarter 2018 Financial Results
07/08/2018
WALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Allena Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
07/08/2018
- Enrolling Global Phase 3 URIROX-1™ Trial; Plan to Initiate URIROX-2™ in 2H18 - - Treated First Patients in Phase 2 Basket Study of Reloxiliase (ALLN-177) for Primary Hyperoxaluria or Enteric Hyperoxaluria with [...]
Rexahn Issues Mid-Year Shareholder Letter to Review Recent Progress and Clinical Plans
07/08/2018
ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]
Teneobio and Poseida Expand Their Partnership to Develop UniDabs™ for Advanced CAR-T Therapies
07/08/2018
MENLO PARK, Calif. and SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Teneobio, Inc., a next generation multi-specific antibody therapeutics company, and Poseida Therapeutics, Inc., a San Diego-based clinical-stage [...]
UroGen Pharma to Report Second Quarter 2018 Financial Results on Tuesday, August 14, 2018
07/08/2018
Conference Call and Webcast Scheduled for 8:30 AM ET RA’ANANA, Israel and NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN) today announced that it will report second quarter 2018 financial [...]
Progressive Care to Host Conference Call on Second Quarter 2018 Financial Results and Business Update on Aug. 14
07/08/2018
MIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that the company will host a conference call on Tuesday, Aug. 14 [...]
Avivagen Announces Agreement to Terminate China JV
07/08/2018
OTTAWA, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
Establishment Labs to Release Second Quarter 2018 Financial Results on August 14, 2018
07/08/2018
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Establishment Labs (NASDAQ: ESTA) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018, prior to the open of U.S [...]

Pages